Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 339

Frichti cooks up $13.6m series A

Meal delivery service Frichti has added Idinvest, the private equity firm backed by corporates including Allianz, to its shareholders.

Mar 31, 2016

Idinvest helps shift $14m to Planday

Corporate-backed Idinvest Partners has led a funding round for Planday, the developer of a workforce management service aimed at shift-based companies.

Mar 31, 2016

Tengelmann shows enthusiasm for massage service Zeel

Tengelmann led the $10m first close of a $12m funding round that will help on-demand massage provider Zeel expand to additional cities.

Mar 30, 2016

Maat Pharma balances out series A with $11m

Biocodex led the round, which will fund the start of clinical studies for Maat's microbiome-based dysbiosis treatment this summer.

Mar 29, 2016

Fove heads past series A stage with $11m

The virtual reality headset startup raised the money in a Colopl-led round that also featured Samsung and Foxconn.

Mar 24, 2016

Syntimmune lets in Baxalta in $10m raise

Baxalta's corporate venturing unit contributed to the $10m second tranche of the autoimmune disease drug developer's series A round, expected to close at $26m.

Mar 23, 2016

TMC goes HomeUnion in $16m round

Online property investment manager HomeUnion increased its overall funding to $23m in a series B round backed by TMC Group's Tamarisc unit.

Mar 23, 2016

Sight Machine manufactures $13.5m series B

GE Ventures joined existing investor O'Reilly AlphaTech for a round that the manufacturing analytics company will spend on sales, marketing and product development.

Mar 22, 2016

Unilever explores Mirriad opportunities in $15m round

The in-video advertising technology producer will use the Unilever-backed round to scale its technology and form new content partnerships.

Mar 22, 2016

Topas emerges from Evotec with $15.7m

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

Mar 22, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here